목적: There is a paucity of literature regarding COVID-19 related tracheostomy outcomes, and the optimal timing and patient selection criteria in this setting remain to be elucidated. In this study, we report outcomes in the first sixty (60) COVID-19 patients who underwent tracheostomy at our institution. 방법:This is a two-year, single-center, retrospective, descriptive study of patients confirmed to have COVID-19 who underwent tracheostomy. The primary outcome measure was 30-day survival. Secondary outcomes included duration of ventilation, intensive care unit (ICU) and hospital length of stay, and post-tracheostomy endoscopy outcomes. 결과:A total of 60 patients with COVID-19 who were admitted to the ICU between April 2020 and October 2022, underwent tracheostomies by the Department of Otorhinolaryngology Head and Neck Surgery of St. Lukes Medical Center. The survival rate was 36/60 (60%). Among tracheostomized patients that survived, the majority were male (21/36), Filipinos (36/36), classified as Critical Covid infection (34/36), and were unvaccinated for COVID-19 (29/36). Most of the patients were inflicted during 2021 (27/36). The timing for elective tracheostomy did not affect the survival rate of the patients. There is also no significant difference in the pre- operative or baseline laboratory values of the survivors and non-survivors. 결론:The 30-day survival outcomes of COVID-19 patients who underwent Tracheostomy in our institution are consistent with published studies, with 60% survival rate. Preoperative patient optimization and selection are beneficial for the success and safety of these patients.